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Background: The cryopreservation and thawing processes are known to induce many deleterious effects in cells
and might be detrimental to several cell types. There is an inherent variability in cellular responses among cell
types and within individual cells of a given population with regard to their ability to endure the freezing and
thawing process. The aim of this study was to evaluate the fate of cryopreserved cells within an optical cryo
apparatus, the individual-cell-based cryo-chip (i3C), by monitoring several basic cellular functional activities at the
resolution of individual cells.
Results: In the present study, U937 cells underwent the freezing and thawing cycle in the i3C device. Then a panel
of vital tests was performed, including the number of dead cells (PI staining), apoptotic rate (Annexin V staining),
mitochondrial membrane potential (TMRM staining), cytoplasm membrane integrity and intracellular metabolism
(FDA staining), as well as post-thawing cell proliferation assays. Cells that underwent the freezing - thawing cycle in
i3C devices exhibited the same functional activity as control cells. Moreover, the combination of the multi-
parametric analysis at a single cell resolution and the optical and biological features of the device enable an
accurate determination of the functional status of individual cells and subsequent retrieval and utilization of the
most valuable cells.
Conclusions: The means and methodologies described here enable the freezing and thawing of spatially
identifiable cells, as well as the efficient detection of viable, specific, highly biologically active cells for future
applications.
Background
The preservation of living cells has both theoretical and
practical importance for human medicine, as well as for
veterinary practice, cattle breeding, and plant cultivation
[1-3]. The maintenance of intact living cells is necessary
to preserve the cells’ biological, biochemical, and
functional properties as well as structural integrity, espe-
cially in rare and pedigree species. Of special interest is
the preservation of definite sets of cells carrying specific
antigens as well as stem cells. Such preservation opens
wide possibilities for personalized therapy and for the
development of innovative strategies for treating severe
diseases, such as diabetes, nervous and cardio-vascular
diseases, as well as various types of tumors [4-7].
The effects of freezing and thawing on the biophysical
and biochemical features of living cells can result in
alteration of their functional competency and survival
[8]. Recently, numerous research groups have
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thawing and to develop new cryopreservative media and
instruments in order to minimize the damage caused by
the freezing - thawing cycle (FTC) and to improve cell
survival [1,9,10]. However, the ability to evaluate cell
vitality potential, proliferation, and functional activity
before and after cryopreservation is still limited.
We have recently introduced a novel device: the indi-
vidual-cell-based cryo-chip (i3C) for the cryopreserva-
tion, manipulation and observation of spatially
identifiable cells [11]. The aim of the present study is to
evaluate the fate of cryopreserved cells in the device and
to develop an approach for the efficient detection of
viable, specific, highly biologically active cells for future
applications. The results showed that U937 cells, after
being thawed, have the same functional activities as
non-frozen cells, confirming their biological integrity.
Moreover, quantitative image analysis at the resolution
of individual cells facilitated the detection of unique,
bioactive single cells or cell groups, within heteroge-
neous cell populations.
Methods
The Individual-cell-based cryo-chip (i3C)
The i3C is a configured micro-fluidics slide device, based
on our previous work [12]. A detailed description of its
mechanical and methodological aspects has been recently
reported [11]. Briefly, the i3C is designed for holding
individual cells or individual cell groups throughout cryo-
preservation, manipulation, and observation. The active
area is a 2.5 μl chamber with a bottom which is made of
densely packed transparent hexagonal matrix arrays of
micron-sized wells (Figure 1). The high optical quality of
the picowells enables high content image analysis of the
cells maintained in the picowells, during their bio-manip-
ulation, at an individual cell resolution.
Biomaterials and probes
Propidium iodide (PI) and dimethyl sulphoxide (Me2SO)
were obtained from Sigma-Aldrich (St.Louis, MO, USA).
Annexin V - FITC Apoptosis detection kit was obtained
from BioVision Inc. (Mountain View, CA, USA). Fluores-
cein diacetate (FDA) was purchased from Sigma-Riedel-
de-Haen (Hanover, Germany). Tetramethylrhodamine
methyl ester perchlorate (TMRM) was obtained from
Molecular Probes (Eugene, Oregon, USA). RPMI-1640
medium, heat-inactivated fetal calf serum, penicillin,
streptomycin, glutamine, sodium pyruvate and HEPES
(all for the complete medium) were obtained from Biolo-
gical Industries (Kibbutz Beit Haemek, Israel).
Cells and culture media
Human pro-monocytic U937 cells (ECACC, UK) were
maintained in RPMI-1640 medium supplemented with
10% heat-inactivated fetal calf serum (FCS), 100 U/ml
penicillin, 100 μg/ml streptomycin, 2% glutamine, 2%
sodium pyruvate and 2% HEPES. Cells were maintained
in completely humidified air with 5% CO2 at 37°C.
Before use, exponentially growing cells were obtained,
washed, and resuspended in PBS at a concentration of
1.5-2.0 × 10
6 cells/ml. For post-thawing cell mainte-
nance, the complete medium was supplemented by 20%
FCS. The freezing - thawing cycle was performed in a
cryo-protective medium supplemented by 20% FCS and
10% Me2SO.
Experimental scheme
U937 cells at a concentration of 1.5-2.0 × 10
6 cells/ml
underwent the freezing - thawing cycle in the i3C
(experimental sample, 12 μl), in standard cryo-vials
(control sample, 1 ml), or in mini-vials (control sample,
Figure 1 The individual-cell-based cryo-chip (i3C). (A) The 2.5 ml
cell chamber (1), whose glass bottom contains the picowells (small
opaque region inside the chamber), which are engraved into the
i3C plastic body (2). The cover slip (3) is moved left to enable
access to the cell chamber opening, through which the cell
suspension is loaded. The cover slip is then returned to its position
in order to secure the content of the cell chamber when the liquids
are poured into the entrance of the open conduit (4), formed by
the space between the cover slip and the plastic ‘step bridge’. Flow
to the left is then established via capillary forces developed
between the cover slip, the bridge and the poured liquid. (B) SEM
micrograph of U937 cells in their picowells, as they appear at the
bottom of the cell chamber.
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to test the effect of the cell suspension volume on the
cryopreservation process. In order to avoid a potential
diversity of results due to different cell concentrations,
additional control samples were exposed to the freezing
- thawing cycle in standard cryo-vials, using a regular
cell concentration of 10 × 10
6 cells/ml.
In order to equalize the post-thawing experimental
conditions, control samples (the cell suspensions that
underwent the cryopreservation cycle within the cryo-
vial), were loaded into the i3C after the freezing - thaw-
ing cycle. From that point onward, the cells that were
cryopreserved in the i3C and in the cryo-vial experi-
enced the same experimental and measurement
conditions.
For cell division experiments, control samples (cells
that underwent the cryopreservation cycle within stan-
dard cryo-vials) were transferred immediately after
thawing to 10 ml fresh enriched medium in culture
flasks. Untreated U937 cells were cultured in standard
conditions as described above.
Two types of i3C were used in this study: 20 μma n d
100 μm pitched. The former were used for single cell
maintenance, while the latter were used for maintaining
groups of cells in a single picowell.
Cell loading
Cell loading into the i3C, whether for experimental sam-
ples or control samples, was carried out as follows: 5 μl
o fc e l ls u s p e n s i o n( 1 . 5-2×1 0
6 cells/ml) either in PBS
or cryo-medium, was poured into the cell chamber and
left for 7-10 min for cell sedimentation onto the pico-
well-padded bottom of the chamber. Next, 2.5 μlo f
s u p e r n a t a n tm e d i u mw a sr e m o v e df r o mt h et o po ft h e
suspension drop and the glass cover was closed, allow-
ing for the introduction of a new medium portion
(about 30 μl of total liquid volume) between the cover
slip and the cell array conduit. The cell suspension in
PBS was used for loading experimental samples into the
i3C. After cell sedimentation, PBS was exchanged with
the cryo-medium and the freezing - thawing cycle was
started. For post-thawing loading of U937 cells from
control cryo-devices, the cell suspension in the cryo-
medium was loaded into the i3C as described above.
Accordingly, the cryopreserved medium was exchanged
with fresh complete medium.
The Freezing - Thawing Cycle (FTC)
Experimental samples (i3C) and control cryo mini-vials
underwent the freezing - thawing cycle either in a cryo-
microscope or in a NALGENE Cryo 1°C Freezing Con-
tainer (Thermo Fisher Scientific Inc., Waldham, MA,
USA). An epifluorescence microscope (Eclipse 80i,
Nikon, Japan) which was modified to include a cryostage
(MDBCS 600, Linkam Instruments, UK) cooled with
liquid nitrogen and heated with an electric heating wire
was used. The cooling and heating rates were fully con-
trolled by a TP94 controller. After 15 min of pre-cooling
at 4°C, the freezing procedure was initiated and the
samples underwent slow freezing at a rate of 1°C per
minute. The freezing end point was -80°C. The control
samples in standard cryo-vials were frozen in a NAL-
GENE Cryo 1°C Freezing Container at the rate of about
1°C per minute until reaching -80°C in the Revco Refrig-
erator (Legaci Refrigeration System, Ashville, NC, USA).
Samples were stored at-80°C for at least 15 min (in
cryostage) and up to 4 days in the freezing container.
For long term storage under extremely low tempera-
ture conditions, the samples were transferred into liquid
nitrogen after -80°C was reached. Samples were kept in
liquid nitrogen (-196°C) for at least 2 days.
Thawing was performed as quickly as possible. Within
the cryostage, the thawing of samples stored either in
the i3C or in cryo mini-vials was always performed con-
trollably: the heating rates were set between 40°C and
30°C per minute. The thawing of samples that were fro-
z e ni nas t a n d a r dN A L G E N EC r y o1 ° CF r e e z i n gC o n -
tainer was conducted by placing the frozen sample in an
incubator at 37°C for 3 minutes. On the average, the lat-
ter procedure quite reliably imitates the thawing condi-
tions within the cryostage, as the temperature of the
frozen sample is elevated from-80° to +37° in 3 minutes.
Post-thawing culturing and staining
Following the freezing - thawing cycle, the cryo-medium
was immediately exchanged with pre-warmed complete
medium supplemented with 20% FCS. U937 cells were
incubated in completely humidified air at 37°C with 5%
CO2 for 1.5 hours, 3, 6, 24 and 48 hours. Cell staining
was performed according to the protocols described
below.
Apoptosis screening after the freezing - thawing cycle
T h ee a r l ya p o p t o t i ce v e n t sa n dc e l lv i a b i l i t yw e r ed e t e r -
mined by double staining with an Annexin V and PI kit
according to the manufacturer’s protocol. U937 cells
were washed with binding buffer and then FITC-
Annexin V and PI were added as described in the
instructions. Following 5 min incubation in the dark at
RT, cells were evaluated by fluorescent microscope at
two wavelengths.
Cell proliferation after the freezing - thawing cycle
For cell proliferation experiments, the i3C with 100 μm
picowells was chosen and U937 cells were loaded into
the i3C before the freezing - thawing cycle. The cell
proliferation was monitored for up to 48 hours, by tra-
cing the number of cells within each individual group
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thawed U937 cells of the corresponding cell groups
were counted immediately after thawing and after 48
hours.
The post-thawing cell proliferation in the i3C was
compared both with the division of U937 cells under-
went FTC in standard cryo-vials and then transferred to
standard culture flasks as well as with the untreated
U937 cells cultured under standard conditions as
described above.
Cytoplasm membrane integrity and metabolic activity of
U937 cells after the freezing - thawing cycle
The rate of fluorescein-diacetate hydrolysis (FDA, 1.2
μM in PBS) by non-specific esterases was measured in
U937 cells after thawing and was calculated from
repeated periodical measurements (5 times, at time
intervals of 60 sec) for the same cells [13]. A mixture of
FDA (at a final concentration of 1.2 μM) and PI (at a
final concentration of 2.5 μg/ml) was added to U937
cells loaded in the i3C at RT.
Mitochondrial membrane potential screening in U937
cells after the freezing - thawing cycle
The mitochondrial membrane potential was assessed by
TMRM staining [14]. Following the freezing - thawing
cycle, U937 cells in the i3C were incubated in the pre-
sence of TMRM (final concentration of 200 nM, in PBS)
for 15 min at 37°C, 5% CO2, and then washed with PBS.
Multi-parametric analysis of cell physiological status after
the freezing - thawing cycle
The simultaneous analysis of cells at different physiolo-
gical statuses was performed using multi-parametric
staining by TMRM, FDA, PI and Annexin V. Following
the freezing - thawing cycle, U937 cells in the i3Cs were
first stained by TMRM and by FITC-labeled Annexin V
(as described above), and the fluorescent and trans-
mitted light images were acquired. Then, a mixture of
FDA and PI (see above) was introduced into the i3C
and the same cells were imaged again. The kinetics of
FDA hydrolysis was evaluated as described in the sec-
tion Cytoplasm membrane integrity and metabolic activ-
ity of U937 cells after the freezing - thawing cycle.T h e
coordinates for each acquired area (stage positions)
were saved throughout the experiment. Thus, parallel
analysis of mitochondrial membrane potential, intracel-
lular esterase activity, and apoptosis levels were obtained
for each individual cell.
Measurements and image analysis
An Olympus Cell^R system mounted on an inverted
IX81 microscope (Tokyo, Japan) was equipped with a
sub-micron Marzhauser-Wetzlar motorized stage (type
SCAN-IM, with an Lstep controller, Wetzlar-Steindorf,
Germany), 14-bit ORCA II C4742-98 camera (Hama-
matsu, Japan), and a filter wheel including fluorescence
cubes (excitation filters, dichroic mirrors and emission
filters, respectively: for fluorescein (i.e., FDA and
Annexin V-FITC) 470-490 nm, 505 nm long pass, and
510-530 nm; for TMRM 510-560 nm, 565 nm, 577-632
nm; and for PI 540-580 nm, 595 nm, 600-660 nm. All
filters were obtained from Chroma Technology Cor-
poration (Brattleboro, VT, USA).
Olympus Cell^P software was used for image analysis.
An in-house developed software package was used to
monitor the picowells’ structure for automatic cell
recognition. This module automatically recognizes the
picowells’ structure, creates a region of interest (ROI)
for each picowell and identifies the regions that are
occupied by cells.
Statistical analysis
For each experiment, 2-3 i3Cs were used. For each
device, 4 images from 4 different areas were acquired
(about 500-1000 individual cells total). For proliferation
tests, at least 100 individual picowells/cell groups were
analyzed. The mean and SD for each measured para-
meter were calculated for the different cell populations
under investigation (controls and experiments). All the
values are presented as average ± SD. The comparisons
between experimental and control groups of cryo-
devices were carried out using the ANOVA test for
small sample groups.
Results
Cell viability after the freezing - thawing cycle
The most commonly used functional assay for cell viabi-
lity is the assessment of plasma membrane integrity by
PI exclusion test. Our preliminary results indicated that
immediately after slow freezing and thawing, the viabi-
lity of U937 cells (as measured by the percentage of PI
negative cells) in the i3C was the same as in control
samples, i.e., cells frozen in standard devices (the per-
centages of dead cells were 8.6% ± 3.5 and 9.1% ± 5.6,
in the i3C and in standard vials, respectively). Since
plasma membrane permeability is a late event in the
process of cell death, and due to the fact that cell viabi-
lity decreases during the time after thawing [15,16], cell
death was examined after prolonged post-thawing incu-
bation periods (Table 1).
There was no increase observed in the number of
dead cells during the first 3 hours after the freezing -
thawing cycle, and it remained the same in experimental
(i3C) and in cells frozen under standard conditions. Pro-
longed culturing of post-thawed U937 cells in fresh
enriched medium overnight demonstrated an increase in
the proportion of dead cells both in the experimental
Afrimzon et al. BMC Cell Biology 2010, 11:83
http://www.biomedcentral.com/1471-2121/11/83
Page 4 of 13(i3C) and standard devices samples (Table 1). The per-
centage of dead cells (PI positive) post thawing in the
i3C varied from 5% to 54% in different samples. The
corresponding parameters in the standard device sam-
ples varied from 7% to 32% in the cryo-vial and from
7% to 13% in the mini-vial. The statistical differences
were not significant (P = 0.5). The results of cell viability
overnight after thawing were supported by the evalua-
tion of the vitality of U937 cells which were frozen first
at -80°C and then transferred to liquid nitrogen (-196°
C). The cells frozen in the i3C demonstrated a better
cell survival overnight after thawing in comparison to
cells frozen in standard cryo-vials (P = 0.02). It should
be noted that the level of cell death measured in
untreated U937 cells which were cultured for 24 hours
in i3Cs did not differ from that of untreated cells that
were cultured under the same conditions in standard
flasks (9.3% ± 9.2 and 4.7% ± 2.8 respectively, P > 0.2).
The post-thawing cell death in the current experimen-
tal procedures (cell concentration of 1.5 - 2 × 10
6cell/
ml, see Cell loading above) was compared to the death
of cells frozen at a standard concentration in cryo-vials
(10 × 10
6 cell/ml). No statistical difference was found
overnight after thawing in the percentage of cell death
between the two cryo-protocols, for the low and high
cell concentrations, respectively (P = 0.7).
Cell apoptosis after the freezing - thawing cycle
It has been shown that the low survival of human
embryonic stem cells in conventional slow-cooling cryo-
preservation protocols is predominantly due to apoptosis
rather than cellular necrosis [16]. Other cell types, such
as bone marrow cells, also display a high level of apop-
tosis upon freezing and thawing [17].
The level of apoptosis in U937 cell populations which
underwent freezing and thawing in the i3C or in control
cryo-vials was determined by Annexin V binding to
externalized phosphatidylserine. Under the current
experimental conditions, variable percentages of early
apoptotic cells (Annexin V positive and PI negative)
within different cultures of the U937 pro-monocyte cell
line were found both in untreated and in cryopreserved
cells (Table 2). The average percentage of early apopto-
tic cells 3 hours after the freezing - thawing cycle was
the same for cells in the experimental i3C and for con-
trol device samples (4.3% ± 2.1 and 4.6% ± 1.4, respec-
tively, P=0.1). Wide-ranging results are shown
following overnight incubation of either untreated or
post-thawing U937 cells. However, the average propor-
tion of early apoptotic cells did not differ significantly in
untreated cells, cells that underwent FTC in the i3C, or
in standard cryo-vials (P = 0. 2).
Cell proliferation after the freezing - thawing cycle
Cell maintenance and growth depend on the ability of
cells to divide and proliferate. Hence, apart from the cell
intactness, the ability of cryopreserved cells to grow and
proliferate is a major, essential factor for a successful
cryopreservation process.
Cell division was evaluated using i3C devices with 100
μm picowells. The 100 μm diameter picowells in the
i3C array are large enough to hold several individual
cells (up to 20 cells) in each picowell. The direct count-
ing of the number of individual cells within each group/
Table 1 Cell death in U937 cells after the freezing - thawing cycle
Time after thawing The devices used for FTC
i3C mini-vial Standard cryo-vial
2×1 0
6 cells/ml 10 × 10
6cells/ml
1 hour (after-80°C) 8.7% ± 3.5 9.1% ± 5.6
3 hours (after-80°C) 9.2% ± 5.1 6.3% ± 3.2 12.5% ± 4.1
overnight (after-80°C) 23.4% ± 23.5 11.6% ± 2.3 19.6% ± 10.1 17.5% ± 11.3
overnight (after-196°C) 18.5 ± 2.9 24.6 ± 7.0
U937 cells underwent a freezing - thawing cycle as described in Materials and Methods. The percentage of dead (PI positive) cells was tested at appropriate time
points after thawing. The corresponding temperature end points are presented. Values are average ± SD of 2-3 experiments (500-1000 individual cells).
Table 2 Early apoptosis events in U937 cells after the freezing - thawing cycle
Time after thawing The devices used for FTC Untreated cells*
i3C standard cryo-vial
3 hours 4.3% ± 2.1 (3% - 7%) 9.9% ± 6.2 (1% - 19%)
overnight 10.0% ± 10.0 (2% - 20%) 3.0% ± 2.8 (1% - 5%) 7.0% ± 4.3 (1.5% - 10%)
U937 cells underwent a freezing - thawing cycle as described in Materials and Methods. The percentage of early apoptotic (Annexin V positive and PI negative)
cells was tested at appropriate time points after thawing. Values are average ± SD of 2-3 experiments (500-1000 individual cells). The range of results obtained
for the different experiments (as percentages) is presented in brackets. *Untreated U937 cells, which did not undergo FTC, were evaluated at the corresponding
time points.
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ing facilitates the estimation of the division capability of
the post-thawed cells. Figure 2 shows transmitted light
images of the same U937 cell groups, immediately after
thawing and 48 hours after culturing. As can be seen,
dramatic morphological changes are manifest upon cell
growth and there is an increase in cell numbers.
Analyzing the same picowells immediately after thawing
and 48 hours after thawing showed an increase in cell
number from 9.6 ± 5.3 cells per picowell (total 1,061 indi-
vidual cells) to 10.7 ± 4.6 cells per picowell (total 1,192
individual cells), yielding an average ratio of cell numbers
48 hours post-thawing to time 0 of 1.26 ± 0.71 as com-
pared to a ratio of 1.53 ± 0.57 for U937 cells which under-
went the freezing - thawing cycle at the same cell
concentration within standard cryo-vials and were then
transferred to culture flasks (no statistically significant dif-
ferences, P = 0.1). It should be noted that the proportion
of dead cells 48 hours after thawing was the same for cells
frozen in standard cryo-vials and cultured for 48 hours in
a flask and for experimental cells in the i3C (24.5% ± 3.44
and 23.45% ± 12.4, respectively, P = 0.7). Under standard
culturing conditions, untreated U937 cells (1.5 × 10
6/ml)
double their number within 48 hours.
Analyzing cell division at the resolution of single pico-
wells enabled us to select the specific cell groups that
showed the highest proliferation rates. Indeed, in half of
the picowells an increase in cell number was evident
upon 48 hours of post thawing culturing (the ratio of
cell number at 48 hours to time 0 was 1.58 ± 0.83),
while the other cell subsets exhibited no change or a
decrease in cell number. Such variation in cell division
may be attributed to the different responses of non-syn-
chronized cells to FTC, as previously described [18].
Mitochondrial membrane potential (MMP) after the
freezing - thawing cycle
Mitochondria are essential cell organelles involved in a
variety of cellular activities, including ATP synthesis,
intracellular calcium homeostasis, and both integration
and execution of apoptotic signals. The mitochondrial
membrane potential (MMP) is a major indicator of
mitochondrial function. Higher MMP normally implies
a better mitochondrial function [19]. Moreover, differ-
ences in MMP detected within and between cultured
cells reflect the corresponding differences in mitochon-
drial function or levels of their activity [20].
In the present study, the mitochondrial membrane
potential was evaluated by staining the cells with
TMRM, a potentiometric membrane dye which accumu-
lates in the mitochondria. In normally functioning
TMRM stained cells, the intensity of the fluorescent sig-
nal is high and it is localized mainly within the mito-
chondria and not in the cytoplasm (Figure 3A,B).
Hence, the mean fluorescence intensity of the TMRM
signal over the cell area (mean FI) reflects the mito-
chondrial trans-membrane potential, while the disper-
sion of the TMRM signal within the cell region (FI
Standard Deviation, FI SD) indicates the spatial distribu-
tion of TMRM staining. High FI SD designates hetero-
geneous staining, e.g., considerable differences between
mitochondrial and cytoplasmic fluorescence intensity.
Untreated, normal TMRM stained U937 cells are char-
acterized by high values of both mean FI and FI SD
reflecting their normal mitochondrial activity (average FI
values 247.7 au ± 55.4 and average FI SD 172.2 ± 41.5).
The MMP after the freezing - thawing cycle was mea-
sured immediately after thawing (within 30 minutes),
after 1.5, 3 and 6 hours.
Figure 2 Cell proliferation after thawing. Bright field images of the cells (objective × 20) in the same individual picowells: A - immediately
after the freezing - thawing cycle, B - following 48 hour culturing. Scale bar: 0.05 mm.
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within 30 min after thawing. However, the average FI of
TMRM-stained cells immediately after thawing was low
compared to unfrozen samples (P < 0.05), indicating a
relatively low mitochondrial trans-membrane potential,
both in the experimental i3C samples (average mean FI
of 100.5 au ± 38.9 and average FI SD 150 au ± 99) and
in control cells frozen in standard cryo-vials (average
mean FI of 131.1 au ± 67.8 and average FI SD of 118.3
au ± 49.3). No statistically significant differences with
regard to both parameters of TMRM staining were
demonstrated between the i3C and samples that under-
went FTC in a standard cryo-vial (P = 0.6).
After 1.5 hours post-thawing, the U937 cells exhibited
MMP values similar to those of control unfrozen cells. Fig-
ure 4A depicts a scatter diagram of mean FI vs. FI SD of
individual U937 cells without freezing and 1.5 hours post-
thawing incubation. It can be seen that both parameters
are similar in unfrozen controls and in the experimental
i3C cell populations. A small (4.2% ± 0.3) subset of
TMRM negative cells (no detectable MMP) appeared
among U937 cells after the 1.5 hour post-thawing period.
The proportion of this TMRM negative cell group was
2.7% ± 1.9 and 6.3% ± 1.5 at 3 and 6 hours post-thawing,
respectively. No statistically significant difference was
demonstrated in the percentage of these TMRM-negative
cells between the cryo-devices (P = 0.1-0.7). These results
are in agreement with the above results that showed a
decrease in cell viability during post-thawing incubation,
as expressed by the PI exclusion test.
Distribution histograms of individual TMRM mean FI
values within U937 cell populations exposed or
unexposed to the freezing - thawing cycle are shown in
Figure 4B. A wide distribution of individual cells’ mito-
chondrial potential values is shown within the unex-
posed U937 cell population. Similar distributions of
individual cells’ FI values are evident after 1.5 hour incu-
bation in the post-thawed cell groups (i3C and cryo-
vials) indicating normal mitochondrial activity. Within
the three cell populations, the cell subgroup which
exhibited a low MMP (TMRM FI < 200 au) is evident.
The percentage of these cells with a low mitochondrial
activity increased following the freezing - thawing cycle
in both cryopreservation protocols (12% and 16% in the
i3C and cryo-vials, respectively), in respect to the
untreated cell population (7%).
At this time (1.5 hours post-thawing), the mean FI and
FI SD in the cell populations exposed to the freezing -
thawing cycle either in the i3C or in the control cryo-vials
(both mini-vials and standard vials) exhibited no statisti-
cally significant differences (Table 3). 24 hours after thaw-
ing, U937 cells in the i3C demonstrated full mitochondrial
recovery and showed mitochondrial activity equal to that
of the untreated cells, with an average mean FI of 527.7 au
± 506.6 and FI SD of 328.3 au ± 257.2 for the cells frozen
in the i3C, and a mean FI of 346.6 au ± 345.6 and FI SD of
215.8 au ± 171.8 for the unfrozen control cells (P =0 . 5
and 0.4, correspondingly).
Cytoplasm membrane integrity and metabolic activity of
U937 cells after the freezing - thawing cycle
The intensity and rate of accumulation of the fluores-
cent product of FDA hydrolysis within the cells reflect
both the enzymatic activity required for the hydrolysis
Figure 3 Mitochondrial staining of untreated U937 cells by TMRM (200 nM), a potentiometric membrane dye which accumulates in
the mitochondria. Images (× 60 magnification): the overlay of transmitted light and fluorescent images (A) and the corresponding fluorescent
image (B) are presented. The white arrow indicates a TMRM negative U937 cell, also characterized by its morphological appearance in the
transmitted light image. Scale bar: 0.02 mm
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Page 7 of 13and the integrity of the cell membrane necessary for the
retention of the product. As a rule, the FDA staining is
used for post-thawing estimation of cell vitality, since in
the cells with damaged membranes, the accumulation of
hydrolyzed fluorescein does not take place and the
intracellular fluorescent signal is not observed [21,22].
Figure 5 presents a representative FDA staining image
of U937 cells exposed to the freezing - thawing cycle in
the i3C, at 3 hours after thawing. The figure demon-
strates good intracellular accumulation of fluorescein in
the majority of cells and the presence of only one non-
stained cell. Moreover, it is clear that this membrane-
compromised cell can be easily distinguished from the
remaining, normal stained cells, based on its morpholo-
gical appearance in the transmitted light image.
Unlike PI and Annexin V staining, FDA staining of
post-thawed U937 cells, as reflected only by the percen-
tage of FDA positive cells, did not change significantly
during the post-thawing incubation. The percentage of
stained cells was 97.2% ± 2.8 and 89.8% ± 11.1 after 3
and 24 hours post-thawing in the i3C, and 89.3% ± 10.3
and 97.5% ± 3.5 for the corresponding time periods for
cells frozen in control cryo-vials. This indicates that this
parameter is not a sensitive marker for post-thawing cell
status. The quantitative analysis of the individual cell
rate of FDA hydrolysis was done by kinetic measure-
ments of fluorescein accumulation and the calculation
of the linear slope of FI increase over time [23,24]. Fig-
ure 6(A-D) shows the FDA staining of U937 cells at 3
hours after thawing, and the calculated staining rates
( F i g u r e6 E ) .A ss e e n ,t h e r ei sal a r g ed i f f e r e n c ei nt h e
linear slopes for individual cells within the entire cell
population, which signifies a large variation in the indi-
vidual metabolic activity. The percentage of post-thawed
cells that exhibited a positive FDA hydrolysis slope was
7 7 . 1±7 . 8a sc o m p a r e dt o8 6±3 . 5i nt h eu n f r o z e nc e l l
population. The mean linear slope for the FDA staining
was 60.2 ± 59.4 in the i3C-frozen cells, very close to
that of the unfrozen U937 cells (62.4 ± 24.5). Figure 7
shows the mean FDA hydrolysis rates in the i3C-frozen
U937 cells and in cells exposed to the freezing - thawing
cycle in the control cryo-devices, as measured 24 hours
after thawing. The statistical differences of the FDA
hydrolysis rates in the cells that underwent the freezing
- thawing cycle in the different cryo-devices were esti-
mated at P= 0.5.
Multi-parametric analysis following the freezing - thawing
cycle in the i3C
The unique optical and mechanical features of the i3C
enabled the observation and treatment of the same indi-
vidual cells, and finding direct associations between sev-
eral parameters at a single cell resolution.
U937 cells underwent the freezing - thawing cycle
within 100 μm diameter i3C devices and then parallel
analyses of mitochondrial membrane potential, intracel-
lular esterase activity, and apoptosis levels at the
resolution of individual cells, were accomplished using
multi-parametric staining by TMRM, FDA hydrolysis
rates, and Annexin V - PI test, respectively, as described
in Materials and Methods,2 4h o u r sa f t e rt h a w i n g
(Figure 8A-C).
According to the established single parameter apopto-
sis assessment using double Annexin V and PI staining,
three cell subgroups were identified:
a. The intact cell population (live cells) - negative for
both Annexin V and PI staining.
b. The late apoptosis cell group as evidenced by the
parallel staining with both PI and Annexin V.
c. Early apoptosis cells characterized by Annexin V
binding but which were PI negative.
Utilizing the i3C methodology, additional analyses of
MMP and esterase enzymatic activity in the same
Figure 4 Characteristics of the mitochondria in U937 cells after
the freezing - thawing cycle (1.5 hours). (A). Scattered diagram
of single cells’ mean FI (X axis) vs. FI SD (Y axis) for individual cells
stained with TMRM in the i3C (1.5 hours after the freezing - thawing
cycle) and unfrozen control. Each dot represents an individual cell.
(B) Distribution histograms of FI values in individual U937 cells that
underwent the freezing - thawing cycle in the i3C, standard cryo-
vials and the unfrozen control.
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Page 8 of 13individual post-thawing U937 cells from the above cell
groups were made. The percentages of the different cell
groups and their corresponding average fluorescence
signals are summarized in Table 4, while single cell
results are illustrated in Figure 8D, in a scatter diagram
of the individual cells’ values of TMRM fluorescence
intensity vs. esterase enzymatic activity.
As Table 4 shows, the late apoptosis cell group (17%
of the post-thawing cells) showed no TMRM staining
and no esterase activity. The intact cell group, which
comprises the majority (62%) of the cell population, is
characterized by high functional activity as reflected by
the maximal TMRM FI and the highest FDA slopes. As
shown in Fig 8D, within this cell cluster, the most vigor-
ous cells are exemplified by the uppermost mitochon-
drial and enzymatic activity and can be easily selected.
Post-thawing cells that underwent early apoptosis
(characterized by Annexin V binding, but which were
negative for PI), display low mitochondrial and enzy-
matic activity. However, in this cell group, two cell sub-
sets were detected based on the quantitative
measurements of individual MMP values. The majority
of this cell group (15% of the total cell population)
showed no mitochondrial activity (TMRM negative) and
low FDA hydrolysis rates and termed MMP
- subgroup.
An additional subset (5% of the total cell population)
exhibited detectable but low mitochondrial membrane
potential (< 30% of the mean FI for the cell population)
along with low FDA hydrolysis rates (< 30% of the
mean slope for the cell population). This subgroup
termed early apoptosis MMP
+ subgroup, and could be
distinguished from the other apoptotic cells by their
TMRM FI values (Figure 8D).
In untreated U937 cells growing in culture, the per-
centage of cells undergoing spontaneous early and late
apoptosis was 12% ± 4% and 5% ± 3% respectively.
Among the early apoptotic subgroup, most of the cells
(9% of the total cell population) were MMP
+ and
showed considerable mitochondrial activity.
Discussion
In recent years, great effort has been dedicated to
improving procedures for freezing and resuscitation of
various cell types and to overcoming or minimizing the
cell damage induced by freezing and thawing [25-27].
Each new approach calls not only for the optimal tech-
nical conditions, but also for noninvasive, simple, and
reliable means to test the outcome of the process. The
current work presents the means and methodologies for
using an optical cryo-apparatus for monitoring several
fundamental functional activities of cryopreserved cells,
utilizing the recently developed i3C cryo-device.
Our results confirmed that spatially identifiable cells
that undergo a freezing - thawing cycle in i3C devices
exhibit the same functional activity as control cells. The
proportions of intact cells and apoptosis rates, as well as
the division of cells frozen and thawed in the i3C, were
similar to those for cells that were frozen under the
same experimental conditions in standard cryo-vessels.
Moreover, the cells displayed a normal functional activ-
ity, as reflected by the multi-parametric quantitative
analysis of the mitochondria status and intracellular
enzymatic activity.
The use of cryopreserved cells is becoming widespread
in drug screening, since cryopreservation per se has been
shown to have minimal effects on pharmacological test-
ing and can be applied to many cell types and cell
assays, including arrested cell division [28]. However, in
the fields of reproductive medicine and cell-based ther-
apy, the ability of the post-thawing cells to divide and
proliferate is crucial. The large picowells (100 μm) of
the i3C enable us to culture and visualize multiple small
Table 3 Mitochondrial membrane potential of U937 cells
after the freezing - thawing cycle
TMRM fluorescence
signal
The devices used for FTC P
i3C mini-vial standard cryo-
vial




814.8 ± 534.4 0.9




624.5 ± 365.6 0.8
U937 cells underwent a freezing - thawing cycle in appropriate cryo-devices
and 1.5 hours after thawing cells were stained by TMRM as described in
Materials and Methods. Mean FI and FI SD values were measured by Image
Analysis in each individual cell. The average mean and SD for each measured
parameter were calculated for the different cell populations under
investigation (controls and experiments) as described in Statistical analysis.
Values are average ± SD of each group of cryo-devices.
Figure 5 Monitoring U937 cell membrane integrity after the
freezing - thawing cycle by FDA staining. The U937 cells were
exposed to the freezing - thawing cycle in the i3C. At 3 hours after
thawing, FDA solution (1.2 μM) was introduced into the i3C and
images were taken 5 minutes after FDA addition. The transmitted
image (A) and corresponding fluorescent image (B) are presented.
The dead U937 cell unstained by FDA is indicated by the red arrow.
Scale bar: 0.01 mm.
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Page 9 of 13cell groups, as well as monitor their behavior and propa-
gation at a single cell resolution. With only a few cells
in each picowell, real-time, kinetic measurements of cell
division can be performed, thus specific non-dividing or
highly proliferative cell clusters can be detected. This
attribute is essential for stem cell clone analyses, where,
after cell divisions, the newly formed compact colony
remains confined to its picowell, enabling time-lapse
imaging of the evolving clone. Moreover, the unique
optical features of the i3C facilitate the morphological
observations of cryopreserved cells in bright field micro-
scopy. Such a non-intrusive, label-free technique is
imperative for the future utilization of the post-thawed
cells in clinical applications.
It has been shown that low mitochondrial activity is
associated with cryo-damage [15]. Mitochondrial dys-
function in porcine oocytes was found to be directly
responsible for the early arrest of pre-implantation
embryos in vitro [29]. An irreversible loss of high mito-
chondrial membrane potential was detected in cryopre-
served mouse embryos [30]. The decrease in MMP was
found to be involved in the activation of caspase-3 and
apoptosis induction [31].
In our cell system, the post-thawing appearance of
TMRM-negative cells probably reflects the total collapse
of MMP, which was seen upon opening the mitochondrial
Figure 6 Metabolic characteristics of U937 cells that underwent a freezing and thawing cycle in the i3C. At 3 hours after thawing the
cells were stained by FDA (1.2 μM) and the kinetics of FI increase were measured. Transmitted light image (A) and the corresponding
fluorescence images (B-D) of U937 cells at 1 minute (B), 3 minutes (C) and 5 minutes (D) after FDA addition. Scale bar: 0.01 mm. (E) Intracellular
staining rates derived from image analysis of the same U937 cells as in A-D. Each line represents the FI vs. time for an individual cell.
Figure 7 Fluorescein diacetate hydrolysis rates at 19 hours
after thawing. For the evaluation of the metabolic recovery after
the freezing - thawing cycle, the cells were stained by FDA and the
linear slope FI(t) was calculated for each single cell by image
analysis. The mean slopes for U937 cell groups that underwent the
freezing - thawing cycle in the cryo-devices (at least 4 experiments
for each cryo-device) are presented as mean ± SD.
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Page 10 of 13permeability transition pore during apoptotic signaling
[19]. However, time dependent recovery of the mitochon-
drial trans-membrane potential as manifested by the
increase in TMRM staining of post-thawed cells 24 hours
after FTC, was shown in the rest of the cell population.
These results are in agreement with previous data [32].
Furthermore, within TMRM-positive cells, the assess-
ment of individual cells’ MMP by temporal and spatial
quantitative analysis of the fluorescence signal was
found to be a very sensitive parameter for cell status fol-
lowing the freezing - thawing cycle. Maximal TMRM
signals accompanied fully functioning cells that were
Annexin V and PI negative and showed the highest
FDA hydrolysis rates. Multi-parametric analysis at the
individual cell resolution is the most significant
achievement of the methodology presented here. Simul-
taneous quantitative measurement of single cells’ MMP,
esterase activity, and phosphatidylserine externalization,
was used to detect the most viable and active cells
within the cryopreserved cell population. All of the
above parameters are well-established apoptosis
markers.
The role of apoptosis in the low recovery rates after
cryopreservation of human embryonic stem cells [10]
and of hematopoietic stem cells and progenitor cells
[33] has recently been emphasized. As a consequence,
new strategies to enhance the post-thawing survival of
such precious cells, by utilizing either protease or apop-
tosis inhibitors have emerged [33,34]. Since different cell
types, at different cell development stages, have varying
Figure 8 Multi-parametric staining of cryopreserved U937 cells. U937 cells were loaded into 100 μm i3C and underwent a freezing -
thawing cycle. After 24 hours of post-thawing culture, the U937 cells were stained sequentially first by TMRM and Annexin V and next by FDA
and PI. Transmitted light (A) and fluorescent images of U937 cells stained with TMRM and Annexin V (B), and FDA (C) are presented. Arrows
indicate different cell statuses: Blue - high functional activity - morphologically intact, highly TMRM and FDA positive, Annexin V negative; Yellow
- early apoptosis - a morphologically changed cell with a slightly condensed nucleus, exhibiting low TMRM staining, FDA positive staining and
strong Annexin V staining; White - late apoptosis - a morphologically changed cell with nucleus defragmentation and pronounced Annexin V
positive staining, TMRM and FDA negative staining. Scale bar: 0.05 mm. (D) Scatter diagram of individual TMRM (FI) values vs. esterase enzymatic
activity values (slopes), measured in post-thawed U937 cells 24 hours after cell thawing. Note the detection of 4 cell subgroups based on their
functional activity parameters.
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Page 11 of 13sensitivities to cryopreservation-induced apoptosis, the
ability to assess the rate of apoptosis in individual post-
thawed cells is crucial.
Moreover, the variability of the kinetics of the death
course within cell populations calls for monitoring sev-
eral apoptotic parameters occurring in single or sub-
groups of cells within a complex population.
The presented i3C device and methodologies address
the above requirements for multi-parametric evaluation
of the program cell-death process at the level of indivi-
dual cells. The system enables not only the detection of
f u l l ya c t i v ea n da p o p t o t i cc e l l sb yt h et r a d i t i o n a l
Annexin V - PI staining, but the depiction of individual
cells and subgroups by the additional simultaneous ana-
lysis of MMP and esterase activity. Thus, the quantita-
tive measurements of individual cells’ TMRM FI and
FDA hydrolysis rates revealed apoptotic subpopulations
which would have been undetected by other methods.
Moreover, among the heterogeneous population of
viable cells, which exhibited variable metabolic and
mitochondrial activities, the selection of the most pro-
mising active cells becomes feasible.
Conclusions
In conclusion, we introduce advanced technological and
analytical capabilities for fluorescence and bright-field
investigation of individual post-thawed cells. Such an
examination reveals the functional and morphological
features of each cell within the population and facilitates
the detection and subsequent retrieval of the most
viable, highly active cells for further utilization.
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